Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Implementation of a Product Lifecycle Management System for Biomedical Research

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Université de Technologie de Compiègne (UTC); Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)); Hôpital Européen Georges Pompidou APHP (HEGP); Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité); Fealinx; Roberval (Roberval); Osiris Canciglieri Junior; Frédéric Noël; Louis Rivest; Abdelaziz Bouras; TC 5; WG 5.1
    • بيانات النشر:
      CCSD
      Springer International Publishing
    • الموضوع:
      2021
    • Collection:
      Université de Technologie de Compiègne: HAL
    • الموضوع:
    • نبذة مختصرة :
      Part 2: Information Technology Models and Systems Implementations ; International audience ; Today’s biomedical research shows similar characteristics with manufacturing industry 20 years ago. Biomedical data are more and more complex and heterogeneous due to recent scientific discoveries and technological innovations. In a previous work, the Product Lifecycle Management (PLM) paradigm was applied to neuroimaging research to manage heterogeneous data and their provenance. A BMI-LM data model and an associated platform were proposed to enable data reuse and sharing in neuroimaging. Here, this application is extended to biomedical data related to Histology, Proteomics, and PET-CT modalities. Data originate from the IVIR laboratory in preclinical research of the Paris Cardiovascular Research Center (PARCC). We proposed a data and workflow integration method and applied them to the collected preclinical data. An extended version of the data model, that we called BMS-LM for BioMedical Study – Lifecycle Management, was developed. Three concepts were added to the data model: Agent, Sample and Intervention. As a proof of concept, samples of imported data from the three identified modalities are given. Results support the use of the BMS-LM data model and system to ameliorate trust of biomedical data and prospectively their reuse.
    • الرقم المعرف:
      10.1007/978-3-030-94399-8_14
    • الدخول الالكتروني :
      https://inria.hal.science/hal-04195233
      https://inria.hal.science/hal-04195233v1/document
      https://inria.hal.science/hal-04195233v1/file/526631_1_En_14_Chapter.pdf
      https://doi.org/10.1007/978-3-030-94399-8_14
    • Rights:
      http://creativecommons.org/licenses/by/ ; info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.CA9B3601